Biocon informs about press release

04 Jun 2016 Evaluate

Biocon has informed about a Press Release dated June 03, 2016 titled ‘Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

388.05 -5.85 (-1.49%)
01-Jan-2026 13:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1251.10
Cipla 1499.55
Zydus Lifesciences 913.35
Lupin 2099.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×